Julian Harrison Analyst PerformanceManaging Director at BTIG ResearchJulian Harrison is a stock analyst at BTIG Research in the medical sector, covering 25 publicly traded companies. Over the past year, Julian Harrison has issued 111 stock ratings, including buy and hold recommendations. While full access to Julian Harrison's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Julian Harrison's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings115 Last 4 YearsBuy Recommendations97.35% 110 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution113RatingsDistribution of strong buy, buy, hold, and sell ratings by Julian Harrison.RatingPercentageCount Strong Buy0.0%0 ratings Buy97.3%110 ratings Hold2.7%3 ratings Sell0.0%0 ratingsOut of 113 total stock ratings issued by Julian Harrison at BTIG Research, the majority (97.3%) have been Buy recommendations, followed by 2.7% Hold.Best & Worst CallsBest Call000.0%TBPHJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AURAOct 2024Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ25 companiesJulian Harrison, an analyst at BTIG Research, currently covers 25 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies100.0%Julian Harrison of BTIG Research specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE18 companies72.0%MED - DRUGS6 companies24.0%LARGE CAP PHARMA1 company4.0% About Julian HarrisonJulian Harrison is a Managing Director and BTIG Biotechnology Analyst. Prior to BTIG, Julian was a Senior Analyst at Tekla Capital Management where he covered small- to large-cap biotechnology and pharmaceutical companies. Previously, he was a Clinical and Translational Research Assistant at Hospital for Special Surgery. Julian earned a BS in biology from Cornell University and an MS in health economics from Weill Cornell Medical College.Follow on LinkedIn Julian Harrison's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTVRDTvardi Therapeutics7/7/2026Reiterated Rating$2.82$15.00Buy$0.0000.00% ROIABVXAbivax6/30/2026Boost Price Target$96.15$175.00Buy$0.0000.00% ROITBPHTheravance Biopharma6/29/2026Downgrade$17.20Neutral$0.0000.00% ROILQDALiquidia6/22/2026Boost Price Target$71.07$109.00Buy$0.0000.00% ROIINVAInnoviva6/22/2026Reiterated Rating$22.67$42.00Buy$0.0000.00% ROIABVXAbivax6/16/2026Reiterated Rating$98.26$150.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics6/16/2026Reiterated Rating$14.33$58.00Buy$0.0000.00% ROISYRESpyre Therapeutics6/15/2026Boost Price Target$83.58$112.00Buy$0.0000.00% ROICLYMClimb Bio6/11/2026Boost Price Target$11.09$20.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics6/9/2026Reiterated Rating$18.00$30.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RNACCartesian Therapeutics6/9/2026Reiterated Rating$6.97$44.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Reiterated Rating$10.55$19.00Buy$0.0000.00% ROIRZLTRezolute6/2/2026Boost Price Target$4.02$6.00Buy$0.0000.00% ROIABVXAbivax6/2/2026Reiterated Rating$129.69$150.00Buy$0.0000.00% ROIJBIOJade Biosciences6/1/2026Boost Price Target$19.02$74.00Buy$0.0000.00% ROIJBIOJade Biosciences5/27/2026Reiterated Rating$21.71$39.00Buy$0.0000.00% ROIAPGEApogee Therapeutics5/27/2026Reiterated Rating$79.23$137.00Buy$0.0000.00% ROIINVAInnoviva5/26/2026Reiterated Rating$22.46$42.00Buy$0.0000.00% ROICGEMCullinan Therapeutics5/19/2026Reiterated Rating$14.87$38.00Buy$0.0000.00% ROIOTLKOncobiologics5/18/2026Reiterated Rating$0.23Neutral$0.0000.00% ROIORKAOruka Therapeutics5/14/2026Reiterated Rating$63.18$151.00Buy$0.0000.00% ROIMREOMereo BioPharma Group5/12/2026Reiterated Rating$0.25$1.00Buy$0.0000.00% ROILQDALiquidia5/11/2026Boost Price Target$51.56$59.00Buy$0.0000.00% ROIINVAInnoviva5/7/2026Boost Price Target$22.52$42.00Buy$0.0000.00% ROICLYMClimb Bio5/6/2026Boost Price Target$11.45$19.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics5/6/2026Boost Price Target$16.26$58.00Buy$0.0000.00% ROICGEMCullinan Therapeutics5/4/2026Reiterated Rating$13.43$38.00Buy$0.0000.00% ROICGEMCullinan Therapeutics4/28/2026Reiterated Rating$12.81$38.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/27/2026Boost Price Target$82.33$151.00Buy$0.0000.00% ROINKTRNektar Therapeutics4/20/2026Boost Price Target$105.21$178.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics4/13/2026Reiterated Rating$13.66$40.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Boost Price Target$59.58$78.00Buy$0.0000.00% ROISYRESpyre Therapeutics4/13/2026Boost Price Target$65.25$98.00Buy$0.0000.00% ROICLYMClimb Bio4/8/2026Reiterated Rating$6.87$8.00Buy$0.0000.00% ROIAKBAAkebia Therapeutics4/7/2026Reiterated Rating$1.32$4.00Buy$0.0000.00% ROITVRDTvardi Therapeutics4/1/2026Reiterated Rating$3.00$15.00Buy$0.0000.00% ROISYRESpyre Therapeutics3/31/2026Reiterated Rating$45.42$70.00Buy$0.0000.00% ROICNTBConnect Biopharma3/31/2026Reiterated Rating$2.90$10.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics3/30/2026Reiterated Rating$17.32$30.00Buy$0.0000.00% ROIMAZEMaze Therapeutics3/25/2026Reiterated Rating$33.55$46.00Buy$0.0000.00% ROIDo NOT Buy SpaceX – Do This Instead (Ad)SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.Read Tilson's free analysis and find out what to do with your moneyAVTXAvalo Therapeutics3/24/2026Reiterated Rating$13.50$40.00Buy$0.0000.00% ROIAPGEApogee Therapeutics3/23/2026Reiterated Rating$80.23$137.00Buy$0.0000.00% ROITBPHTheravance Biopharma3/20/2026Reiterated Rating$14.01$21.00Buy$0.0000.00% ROIAPGEApogee Therapeutics3/16/2026Reiterated Rating$71.90$137.00Buy$0.0000.00% ROIJBIOJade Biosciences3/16/2026Boost Price Target$13.92$39.00Buy$0.0000.00% ROISYRESpyre Therapeutics3/16/2026Reiterated Rating$43.46$70.00Buy$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Reiterated Rating$37.10$73.00Buy$0.0000.00% ROIRNACCartesian Therapeutics3/9/2026Reiterated Rating$9.02Buy$0.0000.00% ROIMAZEMaze Therapeutics3/9/2026Reiterated Rating$44.83$46.00Buy$0.0000.00% ROILQDALiquidia3/5/2026Boost Price Target$34.52$50.00Buy$0.0000.00% ROITBPHTheravance Biopharma3/3/2026Lower Price Target$13.89$21.00Buy$0.0000.00% ROIINVAInnoviva2/26/2026Reiterated Rating$24.24$35.00Buy$0.0000.00% ROIAKBAAkebia Therapeutics2/25/2026Lower Price Target$1.24$4.00Buy$0.0000.00% ROIABVXAbivax2/25/2026Reiterated Rating$128.29$150.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics2/23/2026Boost Price Target$18.68$30.00Buy$0.0000.00% ROIARDXArdelyx2/20/2026Reiterated Rating$6.74$17.00Buy$0.0000.00% ROISYRESpyre Therapeutics2/20/2026Reiterated Rating$41.53$70.00Buy$0.0000.00% ROIINVAInnoviva2/17/2026Initiated Coverage$22.70$35.00Buy$0.0000.00% ROIINVAInnoviva2/17/2026Initiated Coverage$23.85$35.00Buy$0.0000.00% ROINKTRNektar Therapeutics2/10/2026Boost Price Target$52.62$151.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics2/9/2026Reiterated Rating$15.75$24.00Buy$0.0000.00% ROITBPHTheravance Biopharma2/3/2026Reiterated Rating$19.83$40.00Buy$0.0000.00% ROIARDXArdelyx1/29/2026Reiterated Rating$7.86$17.00Buy$0.0000.00% ROINKTRNektar Therapeutics1/29/2026Reiterated Rating$36.16$118.00Buy$0.0000.00% ROISYRESpyre Therapeutics1/16/2026Reiterated Rating$33.56$70.00Buy$0.0000.00% ROIMAZEMaze Therapeutics1/16/2026Boost Price Target$40.42$46.00Buy$0.0000.00% ROIMREOMereo BioPharma Group1/16/2026Reiterated Rating$0.62$1.00Buy$0.0000.00% ROIORKAOruka Therapeutics1/12/2026Boost Price Target$28.89$73.00Buy$0.0000.00% ROILQDALiquidia1/9/2026Reiterated Rating$35.81$49.00Buy$0.0000.00% ROIARDXArdelyx1/9/2026Boost Price Target$7.00$17.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics1/9/2026Upgrade$14.34$24.00Buy$0.0000.00% ROIABVXAbivax1/8/2026Boost Price Target$126.48$150.00Buy$0.0000.00% ROIRZLTRezolute1/8/2026Reiterated Rating$2.35$5.00Buy$0.0000.00% ROIAPGEApogee Therapeutics1/6/2026Set Price Target$75.55$137.00$0.0000.00% ROIAPGEApogee Therapeutics1/5/2026Boost Price Target$75.78$128.00Buy$0.0000.00% ROIMREOMereo BioPharma Group12/29/2025Lower Price Target$0.28$1.00Buy$0.0000.00% ROILQDALiquidia12/26/2025Reiterated Rating$35.48$49.00Buy$0.0000.00% ROIMREOMereo BioPharma Group12/18/2025Reiterated Rating$1.91$6.00Buy$0.0000.00% ROINKTRNektar Therapeutics12/16/2025Boost Price Target$49.16$118.00Buy$0.0000.00% ROIRZLTRezolute12/11/2025Reiterated Rating$1.38$5.00Buy$0.0000.00% ROIAKBAAkebia Therapeutics12/2/2025Reiterated Rating$1.50$5.00Buy$0.0000.00% ROITBPHTheravance Biopharma11/26/2025Boost Price Target$18.94$40.00Buy$0.0000.00% ROICGEMCullinan Therapeutics11/24/2025Boost Price Target$11.69$38.00Buy$0.0000.00% ROIRZLTRezolute11/20/2025Reiterated Rating$10.16$17.00Buy$0.0000.00% ROIRNACCartesian Therapeutics11/14/2025Boost Price Target$7.23$44.00Buy$0.0000.00% ROIORKAOruka Therapeutics11/13/2025Boost Price Target$28.30$63.00Buy$0.0000.00% ROICNTBConnect Biopharma11/13/2025Reiterated Rating$1.61$10.00Buy$0.0000.00% ROILQDALiquidia11/4/2025Reiterated Rating$25.22$49.00Buy$0.0000.00% ROIVRDNViridian Therapeutics11/4/2025Reiterated Rating$23.15$61.00Buy$0.0000.00% ROICNTBConnect Biopharma10/31/2025Initiated Coverage$1.55Buy$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techAKBAAkebia Therapeutics10/29/2025Lower Price Target$2.27$5.00Buy$0.0000.00% ROIPTGXProtagonist Therapeutics10/28/2025Reiterated Rating$75.25$82.00Buy$0.0000.00% ROICLYMClimb Bio10/16/2025Reiterated Rating$1.94$8.00Buy$0.0000.00% ROITVRDTvardi Therapeutics10/13/2025Lower Price Target$6.48$15.00Buy$0.0000.00% ROIJBIOJade Biosciences10/9/2025Initiated Coverage$9.08$28.00Buy$0.0000.00% ROIAPGEApogee Therapeutics10/9/2025Reiterated Rating$50.85$115.00Buy$0.0000.00% ROIJBIOJade Biosciences10/9/2025Initiated Coverage$9.40$28.00Buy$0.0000.00% ROIABVXAbivax10/6/2025Boost Price Target$86.67$120.00Buy$0.0000.00% ROICLYMClimb Bio9/30/2025Boost Price Target$1.99$8.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/29/2025Downgrade$61.99$85.00Neutral$0.0000.00% ROIORKAOruka Therapeutics9/29/2025Reiterated Rating$15.20$56.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics9/29/2025Reiterated Rating$13.02$40.00Buy$0.0000.00% ROICLYMClimb Bio9/22/2025Reiterated Rating$2.32$7.00Buy$0.0000.00% ROINKTRNektar Therapeutics9/19/2025Reiterated Rating$58.76$100.00Buy$0.0000.00% ROIRZLTRezolute9/18/2025Reiterated Rating$7.71$17.00Buy$0.0000.00% ROIORKAOruka Therapeutics9/17/2025Boost Price Target$16.21$56.00Buy$0.0000.00% ROISYRESpyre Therapeutics9/16/2025Reiterated Rating$14.84$70.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/12/2025Boost Price Target$24.80$37.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/10/2025Reiterated Rating$6.47$32.00Buy$0.0000.00% ROIABVXAbivax9/9/2025Reiterated Rating$90.00$112.00Buy$0.0000.00% ROIMAZEMaze Therapeutics9/2/2025Initiated Coverage$14.49$30.00Buy$0.0000.00% ROITBPHTheravance Biopharma6/27/2025Boost Price Target$11.20$25.00Buy$00.0000.00% ROIAURAAura Biosciences10/18/2024Boost Price Target$11.25$24.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftRaymond James FinancialStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
